Occupational effect of sugarcane biomass burning on the conjunctival mucin profile of harvest workers and residents of an adjacent town - A Brazilian panel study

Carregando...
Imagem de Miniatura
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
Citação
EXPERIMENTAL EYE RESEARCH, v.190, article ID 107889, 8p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Pre-harvest burning of sugarcane fields produces large amounts of air pollutants which are known to cause health problems, including ocular surface abnormalities. In this study, we evaluated the effect of biomass burning on mucus quality and mucin gene expression (MUC1, MUC5AC, MUC16) in the conjunctiva of sugarcane workers (SWs) and residents of an adjacent town (RTs). Impression cytology samples of the inferior tarsal and bulbar conjunctiva of 78 SWs and 32 RTs were collected before (T1) and immediately after (T2) a 6-month harvest period. The neutral, acid and total mucus content of goblet cells was determined by PAS and AB staining. The levels of MUC5AC, MUC1 and MUC16 mRNA in the conjunctiva were measured by real-time PCR. Compared to RTs, SWs had higher levels of bulbar acid mucus and MUC16 mRNA and tarsal MUC5AC mRNA at T2 and lower levels of neutral mucus at T1 and T2. In the SW group, MUC1 mRNA levels were higher at T2 than at T1, but the levels of neutral and acid mucus were similar. In the RT group, acid mucus decreased and neutral mucus increased in the bulbar and tarsal conjunctiva at T2. In conclusion, our findings show that sugarcane harvesting is associated with abnormalities in mucus quality and content and changes in mucin mRNA levels on the ocular surface. This may help explain the ocular inflammatory signs and symptoms observed in subjects exposed to air pollutants and high temperatures from sugarcane biomass burning.
Palavras-chave
Air pollution, Sugar cane burning, Ocular surface, Conjunctiva, Mucin, Goblet cell, Inflammation
Referências
  1. Allen AG, 2004, ATMOS ENVIRON, V38, P5025, DOI 10.1016/j.atmosenv.2004.06.019
  2. Amster ED, 2013, ISR MED ASSOC J, V15, P288
  3. Arbex MA, 2014, J EPIDEMIOL COMMUN H, V68, P669, DOI 10.1136/jech-2013-203709
  4. Caffery B, 2008, MOL VIS, V14, P2547
  5. Caffery B, 2010, MOL VIS, V16, P1720
  6. Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008
  7. Corrales RM, 2011, INVEST OPHTH VIS SCI, V52, P8363, DOI 10.1167/iovs.11-7655
  8. da Silva LFF, 2012, ENVIRON RES, V112, P111, DOI 10.1016/j.envres.2011.10.012
  9. Gipson IK, 2004, EXP EYE RES, V78, P379, DOI 10.1016/S0014-4835(03)00204-5
  10. Gipson IK, 2011, CORNEA, V30, P1346, DOI 10.1097/ICO.0b013e31820d852a
  11. Goto DM, 2011, ENVIRON RES, V111, P664, DOI 10.1016/j.envres.2011.03.006
  12. Hodges RR, 2013, EXP EYE RES, V117, P62, DOI 10.1016/j.exer.2013.07.027
  13. Kardon R, 1999, INVEST OPHTH VIS SCI, V40, P1328
  14. Trindade SHK, 2018, ECOTOX ENVIRON SAFE, V148, P608, DOI 10.1016/j.ecoenv.2017.10.041
  15. Lee H, 2013, FREE RADICAL BIO MED, V63, P78, DOI 10.1016/j.freeradbiomed.2013.05.006
  16. Mantelli F, 2008, CURR OPIN ALLERGY CL, V8, P477, DOI 10.1097/ACI.0b013e32830e6b04
  17. Mazzoli-Rocha F, 2008, ENVIRON RES, V108, P35, DOI 10.1016/j.envres.2008.05.004
  18. Menon BB, 2015, MUCOSAL IMMUNOL, V8, P1000, DOI 10.1038/mi.2014.127
  19. Torricelli AAM, 2014, ENVIRON RES, V131, P59, DOI 10.1016/j.envres.2014.02.014
  20. Torricelli AAM, 2011, ARQ BRAS OFTALMOL, V74, P377, DOI 10.1590/S0004-27492011000500016
  21. Mnatzaganian CL, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0067-y
  22. Murube J, 2003, EUR J OPHTHALMOL, V13, P115
  23. Novaes P, 2007, ENVIRON HEALTH PERSP, V115, P1753, DOI 10.1289/ehp.10363
  24. Portal C, 2019, EXP EYE RES, V186, DOI 10.1016/j.exer.2019.107724
  25. Prado GF, 2012, SCI TOTAL ENVIRON, V437, P200, DOI 10.1016/j.scitotenv.2012.07.069
  26. Santos UP, 2015, KIDNEY INT, V87, P792, DOI 10.1038/ki.2014.306
  27. Seriani R, 2015, J TOXICOL ENV HEAL A, V78, P215, DOI 10.1080/15287394.2014.947456
  28. Shimazaki-Den S, 2013, CORNEA, V32, P1211, DOI 10.1097/ICO.0b013e318295a2a5
  29. Tan G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36181-x
  30. Tau J, 2013, INVEST OPHTH VIS SCI, V54, P4759, DOI 10.1167/iovs.12-10541
  31. Yoshizaki K, 2010, INHAL TOXICOL, V22, P610, DOI 10.3109/08958371003621633